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The  BCR  is  composed  of  the  membrane-
bound  Ig  molecule  and  the  Ig/Ig  het-
erodimer signaling subunits. The amino acid 
sequence of the cytosolic tail of Ig is highly 
conserved and contains an immunoreceptor 
tyrosine-based activation motif (ITAM; Reth, 
1989). The ITAM tyrosines of Ig and Ig 
control  the  diverse  signaling  output  of  the 
BCR (Kraus et al., 2004; Gazumyan et al., 
2006). Upon phosphorylation, the two tyro-
sines of the ITAM are bound by the protein 
tyrosine  kinase  (PTK)  Syk  (Grucza  et  al., 
1999). Although Syk controls both prolifera-
tion and differentiation of B and pre–B cells, 
the Syk substrate SLP-65 (also known as BLNK) 
mostly promotes differentiation (Herzog et al., 
2009). In addition, the BCR provides a sur-
vival signal that uses the PI-3 kinase (PI3K) 
pathway  (Srinivasan  et  al.,  2009).  Recent 
findings suggest that Foxo family transcrip-
tion factors also induce differentiation of pre–
B cells, whereas signals from PI3K negatively 
control this process by causing the degrada-
tion of Foxo proteins (Amin and Schlissel, 
2008; Herzog et al., 2008). Interestingly, pro-
tein  arginine  methyltransferase  1  (PRMT1) 
was found to methylate the Foxo1 protein, 
thereby inhibiting its phoshorylation and sub-
sequent degradation (Yamagata et al., 2008). 
PRMTs are enzymes that catalyze the transfer 
of a methyl group from S-adenosyl-methio-
nine to the nitrogen atoms of the arginine 
guanidinium group (Gary and Clarke, 1998). 
To date, 12 different PRMTs have been iden-
tified  (Bedford,  2007;  Bedford  and  Clarke, 
2009). Depending on their ability to produce 
either asymmetric or symmetric dimethylated 
arginines, they are designated as type I or II 
enzymes, respectively (Gary and Clarke, 1998). 
PRMTs not only methylate histones in the 
nucleus  but  also  substrates  in  the  cytosol, 
some of which show altered signaling behav-
ior upon methylation (Mowen et al., 2004; 
Blanchet et al., 2005; Lawson et al., 2007). So 
far, however, arginine methylation of mem-
brane-bound components has not been de-
scribed in eukaryotes. We noticed that the 
Ig cytoplasmic tail contains a conserved ar-
ginine (R198) followed by a glycine (G199), 
thus resembling the sequence context (RG) 
found in PRMT substrate proteins (Najbauer 
et al., 1993; Blanchet et al., 2006; Bedford, 
2007). We show in this paper that R198 of 
Ig is constitutively methylated by PRMT1 
and that this modification inhibits PI3K sig-
naling while promoting signals leading to B 
cell differentiation.
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Signals processed through the B cell antigen receptor (BCR) control both the proliferation 
and differentiation of B lymphocytes. How these different signaling modes are established 
at the BCR is poorly understood. We show that a conserved arginine in the tail sequence of 
the Ig subunit of the BCR is methylated by the protein arginine methyltransferase 1. This 
modification negatively regulates the calcium and PI-3 kinase pathways of the BCR while 
promoting signals leading to B cell differentiation. Thus, Ig arginine methylation can play 
an important role in specifying the outcome of BCR signaling.
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RESULTS AND DISCUSSION
Ig cytoplasmic tail is methylated by PRMT1
A comparison of the Ig tail sequences from several mammals 
(mouse, human, and bovine) reveals a conserved arginine resi-
due (R198) situated in close proximity to the last ITAM 
tyrosine (Y193; Fig. 1 A). The emerging role of arginine meth-
ylation in lymphocytes prompted us to investigate whether 
Ig might be modified by PRMTs.
To test for this, we used a radioactive in vitro methylation 
assay using the immunopurified, hemagglutinin (HA)-tagged 
enzymes PRMT1, 3, 5, and 6 with either glutathione S-trans-
ferase (GST) or GST-Ig (mouse cytoplasmic domain) as sub-
strates. After a 1-h reaction, only PRMT1 incorporated methyl 
groups into proteins of the reaction mix, including a protein 
of the size of GST-Ig (Fig. 1 B, top, lane 4, asterisk). Equal 
loading was confirmed with anti-GST and anti-HA antibodies 
(Fig. 1 B, middle and bottom), and the activity of all purified 
PRMT enzymes was verified using histone H2A as substrate 
(Fig. 1 C). This analysis showed that the cytoplasmic tail of 
Ig is a specific substrate of PRMT1 in vitro.
To verify that R198 is the target of PRMT1, we replaced 
R198 in the tail of Ig with a lysine (K198). The analysis of 
GST-Ig fusion proteins with either WT or K198 mutant tails 
in the radioactive in vitro methylation assay showed that only 
the GST-IgWT but not the K198 mutant is methylated by 
PRMT1 (Fig. 1 D, top). Therefore, R198 is the only PRMT1 
target site in the Ig tail sequence.
To test whether Ig is methylated in B cells, we used ex 
vivo–cultured pro–B cells derived from the BM of mb-1//
B1-8 knockin mice. Because of the deletion of the mb-1 gene, 
these pro–B cells (Ig KO) do not produce Ig but express 
the B1-8 H chain from a VHDJH knockin allele (Pelanda et al., 
2002). Transfection of these pro–B cells with retroviral vec-
tors encoding a  L chain and a flag-tagged Ig results in the 
expression of a BCR that binds to the hapten 4-hydroxy-5-
iodo-3-nitrophenyl acetyl (NIP; Reth et al., 1978; Meixlsperger 
et al., 2007).
To monitor arginine methylation of Ig more directly, 
we generated an anti–Rm-Ig antibody that specifically rec-
ognizes the monomethylated form of R198 (Fig. S1). With 
this antibody, we detected Ig methylation in Ig KO B cells 
stably expressing IgWT (Fig. 2 A, top, lane 1). The R198 
methylation was prevented by treatment of the B cells with 
the PRMT1 inhibitor 35605 (Fig. 2 A, top, lane 2; Spannhoff 
et al., 2007). To obtain more direct evidence that PRMT1 
methylates R198 of Ig, we performed a PRMT1 knockdown 
experiment in HEK293 cells stably expressing a CD8-Ig 
chimeric protein. Interestingly, the Ig cytoplasmic tail is also 
methylated in these cells, and it is dramatically decreased by 
small interfering RNA (siRNA) that reduces PRMT1 pro-
duction (Fig. 2 B).
Using sorted B cell populations from the BM and spleen, 
we found that PRMT1 is expressed in all B cell subsets ex-
amined with the highest amount in pre–B cells (Fig. 2 C, 
top). The parallel analysis of R198 methylation revealed that 
Ig is methylated in all BCR+ cell subsets but not in pre–B 
Figure 1.  Arginine methylation of the Ig tail by PRMT1.  
(A) Sequence alignment of part of the Ig cytoplasmic tail from mouse 
(m), human (h), and bovine (b) is depicted. The asterisk shows the position 
of the conserved arginine. The core region of the ITAM sequence is indi-
cated, as well as the position of tyrosine 193 and arginine 198. (B) In vitro 
methylation assay of GST and GST-Ig fusion protein by immunoprecipi-
tated HA-tagged PRMT1, 3, 5, and 6. Arginine methylation of GST-Ig () 
was detected by autoradiography (lane 4, asterisk). The amount of GST 
() and GST-Ig proteins was revealed with an anti-GST antibody. An 
immunoblot with an anti-HA antibody shows the total amount of PRMTs 
used in the methylation reaction. (C) In vitro methylation assay of histone 
H2A by immunoprecipitated HA-tagged PRMTs. Methyl-3H incorporation 
was detected by autoradiography. The total amount of PRMTs was deter-
mined with an anti-HA antibody. (D) GST-Ig (WT) and GST-IgK198 
mutant (K) were used in the in vitro methylation assay by immunopre-
cipitated HA-tagged PRMT1. Autoradiography shows methylated Ig 
(lane 1). Equal loading was determined by immunoblotting with anti-GST 
and anti-HA antibodies. Apparent molecular weights are indicated. One 
representative experiment out of three is shown.JEM VOL. 207, April 12, 2010  713
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analyzed  for  methyl-3H  incorporation  by  autoradiography 
(Fig. 2 E, top). Radioactive methyl groups were predominantly 
incorporated into IgWT and to a much lesser extent into the 
IgK198  mutant.  The  weak  radioactivity  of  the  IgK198 
mutant may be caused by an incomplete inhibition of protein 
synthesis that resulted in some incorporation of [3H]methionine 
in newly synthesized Ig. Interestingly, the methylation of 
IgWT was strongest in nonstimulated B cells, declined 2.5 
and 5 min after BCR ligation, and reappeared after 30 min of 
exposure of B cells to NIP-BSA (Fig. 2 E, top). We controlled 
for similar amounts of precipitated Ig protein with an anti-
flag antibody (Fig. 2 E, middle). Furthermore, similar amounts 
of methylated proteins in the total cellular lysates of the cells 
demonstrated equal 3H incorporation (Fig. 2 E, bottom). This 
is in line with equal expression of PRMT1 in untransfected as 
well as in Ig-expressing B cells (Fig. S3, top). The time-
course experiment was then repeated using the specific anti–
Rm-Ig antibody to detect R198 methylation in the total 
cellular lysate of WT or mutant Ig–producing B cells. Again, 
cells (Fig. 2 D, top). It has been reported that the pre-BCR 
constitutively produces an autonomous ligand-independent 
signal (Meixlsperger et al., 2007). The finding that Ig meth-
ylation was detected in B cells but not in pre–B cells suggests 
that the R198 methylation has an inhibitory role.
BCR activation alters Ig arginine methylation
To investigate whether the tail of Ig is also methylated upon 
B cell activation, we reconstituted Ig KO cells with both 
IgWT or IgK198 mutant and L chain. A FACS analysis 
verified that transfectants producing either IgWT or the 
IgK198 mutant express similar amounts of BCR on the sur-
face (Fig. S2, top).
The transfected B cells were cultured for 3 h with L-
[methyl-3H]methionine in the presence of protein synthesis 
inhibitors. The cells were then either left unstimulated or 
stimulated for different times (2.5–30 min) with NIP-BSA 
(Fig. 2 E). The Ig proteins in the total cellular lysate of these 
cells  were  immunopurified  with  anti-flag  antibodies  and 
Figure 2.  Alteration of Ig arginine methylation upon BCR activation. (A) B cells containing WT Ig were treated without () or with (+) 50 µM 
PRMT1 inhibitor (35605). Ig arginine methylation was detected with an anti–Rm-Ig antibody (top). An equal amount of Ig is shown by immunoblot-
ting with an anti-flag antibody. (B) HEK293 cells stably expressing CD8-Ig were transfected with nontargeting siRNA (lane 1) or siPRMT1 (lane2). The 
whole-cell lysates were analyzed by immunoblotting with anti–Rm-Ig, anti-Ig, anti-PRMT1, and antiactin. (C and D) Western blot analysis of primary 
cells sorted from BM (pre–B cells) and spleen (transitional [T], follicular [FO], and marginal zone [MZ]). PRMT1 protein levels and Ig arginine methylation 
are indicated with an anti-PRMT1 antibody (C) and with an anti–Rm-Ig antibody (D), respectively. A loading control is shown with antiactin (C) and with 
anti-Ig (D) antibodies. (E) In vivo methylation assay. B cells carrying WT or mutant Ig were labeled with L-[methyl-3H]methionine in the presence of 
protein synthesis inhibitors. Cells were stimulated as indicated with NIP-BSA for different time points. Ig was further immunoprecipitated (IP) with an 
anti-flag antibody, and arginine methylation (Rm-Ig) was revealed by autoradiography (top). The total amount of immunoprecipitated Ig was detected 
with an anti-flag antibody (middle). Equal methylation was determined by measuring 3H incorporation in the total lysate (bottom). In each panel, the 
vertical black lines separate two different parts of the same membrane. (F) B cells expressing WT or mutant Ig were activated with antigen for the indi-
cated times. Ig arginine methylation was detected by immunoblotting with an anti–Rm-Ig antibody. The total amount of Ig was measured with an 
anti-flag antibody. Apparent molecular weights are indicated. Data are representative of three independent experiments.714 Arginine methylation modifies BCR signaling | Infantino et al.
the PTKs Syk and Lyn and the phosphorylation of several PTK 
substrates, including Ig. A time-course experiment moni-
toring tyrosine phosphorylation after stimulation of the BCR 
with NIP-BSA did not show any major difference between 
B cells expressing WT or mutated Ig (Fig. 4 A, top). How-
ever, by using site-specific antibodies detecting either the phos-
phorylation of Y630 in the C-terminal tail of Syk (Kulathu et al., 
2008) or phosphorylation of S473 in the serine/threonine 
kinase AKT/PKB, we found that both proteins are more 
strongly phosphorylated in B cells expressing a BCR with the 
IgK198 mutant than in those carrying IgWT (Fig. 4 B, 
top and middle). Interestingly, after 30 min of BCR stimula-
tion, the phosphorylation of these proteins declines, whereas 
arginine methylation of Ig reappears (compare Fig. 2 E,   
Fig. 2 F, and Fig. 4 B). This inverse correlation between 
phosphorylation and arginine methylation suggests that the 
methylation of R198 of Ig plays a negative regulatory 
role for B cell activation.
The R198 is situated only 5 aa after the last ITAM tyro-
sine (Y193), and it is feasible that methylation of R198 may 
interfere with the binding of Syk to the BCR. To examine 
this, we purified the BCR containing either IgWT or 
IgK198 mutant at different time points after B cell activa-
tion and found that 2–5 min after stimulation, Syk is more 
Ig R198 methylation was high in resting B cells, reduced 2.5 
and 5 min after BCR activation, and reappeared at later time 
points (Fig. 2 F, top). These data, together with the absence of 
Ig methylation in pre–B cells, suggest that R198 methylation 
is a feature of the BCR on resting B cells.
To directly test for Ig–PRMT1 interaction, we used the 
Duolink in situ proximity ligation assay (PLA). Intriguingly, 
PRMT1 appeared to be most strongly associated with Ig 
before activation (Fig. 3 A, top right). At 2.5 min after BCR 
activation, PRMT1 partially dissociated from Ig to further 
reassociate with it at later time point (Fig. 3 A, bottom). The 
time course of Ig–PRMT1 interaction correlates well with the 
kinetics of Ig methylation. No signal was visible in the Ig KO 
control cells (Fig. 3 A, top left). The number of dots per cell 
were counted and plotted with the relative statistical calcula-
tions (Fig. 3 B). The specificity of this assay was also con-
firmed by analyzing the Ig–Syk interaction, which occurred 
only after BCR activation (Fig. 3, C and D).
Arginine methylation of Ig modulates BCR activation
To examine the role of Ig arginine methylation in BCR 
signaling, we compared the behavior of B cells expressing 
either IgWT or the IgK198 mutant. One of the earliest 
events after the engagement of the BCR is the activation of 
Figure 3.  PRMT1–Ig interaction is regulated upon BCR activation. (A) Ig–PRMT1 binding was visualized in B cells using in situ PLA. Ig KO cells 
(Co) reconstituted with IgWT were stimulated with NIP-BSA for the indicated time points. Bars, 10 µm. (B) The dots per cell were counted and plotted. 
Each data point represents a single cell and the bars indicate mean values (*, P < 0.04; and **, P < 0.01 vs. nonactivated B cells). (C) IgWT-expressing B 
cells were activated with antigen and Ig–Syk interaction was detected using in situ PLA. Bars, 10 µm. (D) Each point is a single cell. Bars indicate mean 
values (**, P < 0.01 vs. nonactivated B cells). Nuclei were stained with Hoechst. The experiment was repeated two times with similar results.JEM VOL. 207, April 12, 2010  715
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and not the mutation of Ig per se that increases the Ca2+ 
response in mutant B cells. Furthermore, when the PRMT1 
inhibitor was applied to B cells expressing the IgK198 mutant, 
no further augmentation in calcium flux was observed upon 
stimulation (Fig. 5 C), suggesting that the methylation of Ig 
rather than that of other PRMT1 substrates controls the in-
tensity of the Ca2+ signal.
Ig arginine methylation supports B cell differentiation
The cytokine IL-7 is an important growth factor for mouse 
pre–B cells. The removal of IL-7 from pre–B cell cultures results 
in growth arrest of the pre–B cells and their increased differ-
entiation, as indicated by L chain gene ( followed by ) as-
sembly and the expression of a BCR on the surface of these 
cells (Rolink et al., 1991; Flemming et al., 2003). By com-
paring the amount of BCR+ cells generated after withdrawal 
of IL-7 from pre–B cell cultures expressing either IgWT or 
the IgK198 mutant, we noticed that the latter cells display a 
partial block in B cell differentiation (Fig. 5 E). 5 d after IL-7 
removal, the IgWT cultures contained 14% of BCR+ cells, 
whereas parallel cultures of mutant pre–B cells contained 
only 5.5% BCR+ cells (Fig. 5 E, bottom; and Fig. S4 A). To 
test whether arginine methylation mediated by PRMT1 was 
strongly associated with the mutant than with the WT BCR 
(Fig. 4 C, top). These data support the notion that the meth-
ylation of R198 can modulate BCR signaling.
Ig arginine methylation negatively controls Ca2+ signaling
B cells respond to BCR ligation with a rapid increase in the 
intracellular Ca2+ concentration (Scharenberg et al., 2007). 
We compared the Ca2+ response of NIP-BSA–stimulated B 
cells expressing either WT or an IgK198 mutant BCR. The 
Ca2+ influx was clearly higher in the B cells with the mutant 
BCR (Fig. 5 A). The same was true for cells expressing a 
mutant pre-BCR and stimulated with anti-IgM antibodies 
(Fig. 5 D). The mutant pre-BCR was expressed at similar 
levels to the WT pre-BCR (Fig. S2, bottom). The increased 
B cell response could be caused by the R→K198 mutation 
itself or by the absence of Ig methylation. To test this, we 
stimulated cells expressing the WT BCR with NIP-BSA in 
the absence or presence of the PRMT1 inhibitor 35605 and 
monitored the calcium flux of the stimulated B cells. Inter-
estingly, the inhibition of PRMT1 in stimulated cells ex-
pressing IgWT resulted in a calcium response increased to a 
level similar to that seen in IgK198 mutant B cells (Fig. 5 B). 
This finding indicates that it is the absence of methylation 
Figure 4.  Ig methylation plays a negative role in BCR signaling. Ig KO cells reconstituted with WT or mutant Ig (K) and 1 were stimulated 
with NIP-BSA for the indicated time points. (A) Western blot analysis of whole-cell lysates is shown with antiphosphotyrosine (4G10) and anti-Syk anti-
bodies. (top) A horizontal black line separates the short exposure (top part) from the long exposure (bottom part). (B) B cells expressing WT or mutant Ig 
were activated with antigen for the indicated times. Whole-cell lysates were immunoblotted with anti-pSyk (Y630) and anti-pPKB (S473) antibodies. 
Equal loading is shown with the antiactin antibody. (C) Ig KO () cells carrying WT or mutant Ig (K) and 1 were stimulated with NIP-BSA for the indi-
cated times. Ig was further immunoprecipitated (IP) with an anti-flag antibody and Syk was detected with an anti-Syk antibody (top). The total amount 
of immunoprecipitated Ig was revealed with an anti-flag antibody. The amount of Syk in the whole-cell lysate is shown by immunoblotting with an 
anti-Syk antibody (bottom). Apparent molecular weights are indicated. Similar results were obtained in three independent experiments.716 Arginine methylation modifies BCR signaling | Infantino et al.
programs. Recently, it was discovered that Foxo family tran-
scription factors promote the differentiation of pre–B cells 
and that signals processed through Syk and the PI3K path-
ways counteract this activity by degrading Foxo proteins (Amin 
and Schlissel, 2008; Herzog et al., 2008). Our finding that the 
R→K198 mutation increases Syk and PI3K signaling of the 
BCR and reduces the differentiation signal of the pre-BCR 
is in line with these data.
Ig arginine methylation appears to damper signals from 
the BCR. In pre–B cells, Ig methylation is absent and the 
pre-BCR signals constitutively. Because receptor editing 
or B cell deletion removes cells with autoreactive BCR 
(Nemazee and Bürki, 1989; Gay et al., 1993), it is feasible 
that stronger signaling from BCR lacking Ig arginine meth-
ylation could also lead to negative selection. This may explain 
why the development of pre–B cells carrying IgK198 mu-
tant is impaired.
Finally, the dynamic changes in arginine methylation of 
Ig we detected after BCR stimulation suggest that not 
only  arginine  methylases  but  also  arginine  demethylases 
might modulate B cell activation. It is feasible that upon 
activation, the dissociation of PRMT1 from the BCR al-
lows the recruitment of an arginine demethylase. Indeed, 
the Ig–PRMT1 interaction corresponds to the kinetics of 
required for efficient B cell differentiation, we cultured IgWT 
pre–B cells for 4 d without IL-7 in the presence of different 
doses of the PRMT1 inhibitor 35605 (Fig. 5 F; and Fig. S4 B). 
At the highest dose of inhibitor, the number of BCR+ cells 
was reduced fivefold.
To test the in vivo function of R198 in B cell development, 
we reconstituted pro–B cells derived from Ig KO mice with 
an expression vector either for GFP, IgWT-IRES-GFP, or 
IgK198-IRES-GFP. The cells were sorted for GFP expres-
sion and transferred into RAG-2//gc/ mice. The devel-
oping B cells were analyzed 10 d later. In the spleen, most of 
the pre–B cells expressing WT Ig developed into BCR+ cells 
(67.7% IgM+), whereas pre–B cells carrying IgK198 pro-
duced fewer IgM+ cells (19.7%; Fig. 6 A). Similarly, in the BM, 
although the majority of WT Ig-expressing pre–B cells be-
came IgM+, only a few of the mutant cells developed into IgM+ 
cells (Fig. 6 B). In comparison to WT cells, a higher amount 
of IgK198-expressing cells was found in the BM (Fig. 6 C, 
right). In the spleen, this situation was reversed (Fig. 6 C, 
left). This finding shows that Ig methylation is important 
for regulating B cell differentiation.
The expression of a functional pre-BCR is required for 
both the proliferation and the differentiation of pre–B cells. 
Thus, signals from the same receptor result in opposing cellular 
Figure 5.  Increased intracellular Ca2+ release and partial differentiation impairment in cells expressing mutant Ig. (A) Intracellular Ca2+ 
was measured in B cells expressing WT or mutant Ig (IgK198) after BCR antigen stimulation. The control represents the Ig KO cells. (B and C) Be-
fore BCR activation, B cells were treated with 50 µM PRMT1 inhibitor (35605). (D) Pre–B cells carrying WT or mutant Ig (IgK198) were stimulated 
with anti-IgM and Ca2+ flux was measured. The control corresponds to Ig KO cells. (E) Differentiation of pre–B cells was induced by withdrawal of  
IL-7. 4 and 5 d after IL-7 withdrawal,  and  expression was measured by FACS analysis. (F) Pre–B cells expressing WT Ig were cultured without IL-7 
in the absence or presence of PRMT1 inhibitor (35605). On day 4, the amount of  and  positive cells was detected by FACS analysis. The numbers 
represent the percentage of cells expressing L chain. Dead cells stained with propidium iodide were excluded from the analysis. Comparable data were 
obtained in three independent experiments. FSC, forward scatter.JEM VOL. 207, April 12, 2010  717
Brief Definitive Report
pMOWS-IRES-CD8 or pMIG-IRES-GFP. The plasmids pRp261 and 
pRp261-Ig were used to generate the recombinant proteins GST and 
GST-Ig, respectively. The pRp261-IgK198 mutant vector was generated 
by PCR. PRMT1, 3, 5, and 6 were cloned in the pcDNA3.1 vector con-
taining one flag- and two tandem HA-tags at the N terminus.
siRNA. HEK293 cells were stably transfected with CD8-Ig (this chimeric 
protein contains the extracellular and the transmembrane region of the mouse 
CD8 fused with the cytoplasmic tail of mouse Ig). The siRNAs (80 nM 
final concentration) were complexed with Cellfectin (Invitrogen) in Op-
timem medium for 25 min and were applied to the cells. After 4 h, DMEM 
(supplied with 10% FCS without phenol red and antibiotics) was added and 
incubated for 72 h. To target human PRMT1, the siRNA oligonucleotide 
was purchased from Santa Cruz Biotechnology, Inc. The nontargeting con-
trol siRNA was from Thermo Fisher Scientific.
Antibodies and reagents. The following antibodies were used for Western 
blotting: antiphosphotyrosine (4G10), anti-GST (Bethyl Laboratories, Inc.), 
anti-HA (Roche), anti-flag (Sigma-Aldrich), antiactin, and anti-Syk (N19; 
Santa Cruz Biotechnology, Inc.), anti–pY630-Syk (Kulathu et al., 2008), 
anti-PRMT1, and anti–pS473-PKB (Cell Signaling Technology). For 
immunoprecipitation, the following antibodies were used: anti-flag (Sigma-
Aldrich) and anti-HA (12CA5). The anti–methyl-Ig (anti–Rm-Ig) anti-
body was generated by immunizing rabbit with mono–methyl-Ig peptide 
(190–202 aa). Affinity purification of the antiserum was performed to pro-
duce a methyl-specific antibody (Eurogentec).
W. Sippl (Martin-Luther-Universität Halle-Wittenberg, Halle, Germany) 
provided the PRMT1 inhibitor (NSC 35605). The inhibitor was obtained 
from the National Cancer Institute/Developmental Therapeutics Program 
Open Chemical Repository (available at http://dtp.cancer.gov).
In vitro methylation assays. 2 µg GST and GST Ig recombinant pro-
teins were incubated with 10 µl of immunoprecipitated PRMT enzymes. 
0.5  µCi  S-adenosyl-L-[methyl-3H]methionine  (the  methyl  group  donor) 
was added and the reaction was incubated for 1 h at 30°C. The samples were 
loaded on a gel and blotted onto a nitrocellulose membrane.
Ig methylation. The identification and characterization of 
an arginine demethylase is likely to shed light on the regu-
lation of BCR signaling.
MATERIALS AND METHODS
Mice. RAG-2//gc/ mice (Colucci et al., 1999) were used for the in 
vivo differentiation assay. Pro–B cells derived from the mb-1//B1-8 knockin 
mice were retrovirally transduced with the respective vectors and injected 
intravenously into RAG-2//gc/ mice. 10 d later, mice were sacrificed 
to analyze spleen and BM. BALB/c (WT), mb-1//B1-8 knockin, and 
RAG-2//gc/ mice were bred at the animal facility of the Max-Planck-
Institute for Immunobiology. Animal experiments were performed as approved 
by the Regieriungspräsidium Freiburg.
Cell culture, transfection, and retroviral transduction. The pro–B cell 
line was established from mb-1//B1-8 knockin BM cells cultured in Iscove’s 
medium containing 10% heat-inactivated FCS (PAN Biotech GmbH), 
100 U/ml penicillin/streptomycin (Invitrogen), 50 µM 2-mercaptoethanol 
(EMD), and 0.5 ng/ml IL-7 derived from the supernatant of a J558L cell line 
transfected with a vector encoding mouse IL-7. Retroviruses (pMOWS-
IRES-CD8 [Herzog and Jumaa, 2007] and pMOWS-flag-Ig-IRES-CD8, 
pMOWS-flag-Ig-K-IRES-CD8,  pMIG-IRES-GFP,  pMIG-flag-Ig-
IRES-GFP, pMIG-flag-Ig-K-IRES-GFP, and pMOWS-1 [Meixlsperger 
et al., 2007]) were generated by calcium chloride transfection of the Phoenix 
retroviral producer cell line. Supernatants containing retroviruses were har-
vested after 2 d. Viral infection of 2 × 105 pro–B cells was performed by the 
addition of 500 µl of supernatant followed by centrifugation at 1,800 rpm for 
3 h at 37°C. Cells were expanded and sorted based on CD8 or GFP expres-
sion. 1 expression was selected with 1 µg/ml puromycin. The pcDNA3.1-
PRMT plasmids were used to transfect HEK293 cells with the calcium 
phosphate method and were further selected in medium-containing G418.
Plasmids. A cDNA encoding an N-terminal flag-tag mouse Ig (Rolli et al., 
2002) was inserted into pMOWS-IRES-CD8. The R198K mutation was 
introduced by sequential PCR steps. PCR fragments were cloned into a 
DraIII/XhoI-digested pD-flag-Ig plasmid and subsequently transferred into 
Figure 6.  Ig methylation supports B cell development. Ig KO cells (control) infected with IgWT or IgK198 were intravenously transferred into 
RAG-2//gc/ mice. 10 d after injection, the resulting B cells were analyzed by flow cytometry. (A) Splenic B cells are shown in the dot plot with anti-
CD19 and anti-IgM antibodies. The cells were gated on the GFP+ population. The percentages of CD19+IgM+ cells are indicated. (B) The histogram shows 
the amount of BCR (IgM) on the surface of GFP+CD19+ BM cells. (C) The numbers of transferred cells found in the spleen (left) and in the BM (right) are 
plotted. Error bars indicate means + SEM (each with three mice; *, P < 0.04; **, P < 0.01). The cell transfer was performed two times using three mice per 
group per experiment. In these two sets of experiments, the cells were separately infected and sorted based on GFP expression.718 Arginine methylation modifies BCR signaling | Infantino et al.
IgM–Alexa Fluor 647 (Invitrogen). Dead cells were excluded by staining with 
10 µg/ml propidium iodide. FACS analysis was performed with a flow cytom-
eter (FACSCalibur; BD).
Online supplemental material. Fig. S1 shows the specificity of the anti–
Rm-Ig antibody. Fig. S2 depicts BCR and pre-BCR expression in WT 
or mutant Ig-expressing cells. Fig. S3 shows PRMT1 expression in B 
cells. Fig. S4 shows the statistical analysis of the in vitro differentiation assay. 
Online supplemental material is available at http://www.jem.org/cgi/content/ 
full/jem.20091303/DC1.
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